<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Bioequivalence,Australia,Clinical trial,Confidence interval,Digoxin,Food and Drug Administration,Generic drug,Natural log,Pharmacokinetics,Phenytoin,Therapeutic index" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Bioequivalence - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Bioequivalence</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p><b>Bioequivalence</b> is a term in <a href="../../../p/h/a/Pharmacokinetics.html" title="Pharmacokinetics">pharmacokinetics</a> used to assess the expected <i>in vivo</i> biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.</p>
<p>Birkett (2003) defined bioequivalence by stating that, "two pharmaceutical products are bioequivalent if they are pharmaceutically equivalent and their bioavailabilities (rate and extent of availability) after administration in the same molar dose are similar to such a degree that their effects, with respect to both efficacy and safety, can be expected to be essentially the same. Pharmaceutical equivalence implies the same amount of the same active substance(s), in the same dosage form, for the same route of administration and meeting the same or comparable standards."</p>
<p>The <a href="../../../u/n/i/United_States_09d4.html" title="United States">United States</a> <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) has defined bioequivalence as, "the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study." (FDA, 2003)</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Bioequivalence_testing"><span class="tocnumber">1</span> <span class="toctext">Bioequivalence testing</span></a></li>
<li class="toclevel-1"><a href="#Regulatory_definition"><span class="tocnumber">2</span> <span class="toctext">Regulatory definition</span></a>
<ul>
<li class="toclevel-2"><a href="#Australia"><span class="tocnumber">2.1</span> <span class="toctext">Australia</span></a></li>
<li class="toclevel-2"><a href="#Europe"><span class="tocnumber">2.2</span> <span class="toctext">Europe</span></a></li>
<li class="toclevel-2"><a href="#United_States"><span class="tocnumber">2.3</span> <span class="toctext">United States</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">3</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#Further_reading"><span class="tocnumber">4</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Bioequivalence_testing" id="Bioequivalence_testing"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: Bioequivalence testing">edit</a>]</span> <span class="mw-headline">Bioequivalence testing</span></h2>
<p>In determining bioequivalence, for example, between two products such as a commercially-available Brand product and a potential to-be-marketed Generic product, pharmacokinetic studies are conducted whereby each of the preparations are administered in a cross-over study to volunteer subjects, generally healthy individuals but occasionally in patients. Serum plasma samples are obtained at regular intervals and assayed for parent drug (or occasionally metabolite) concentration. Occasionally, blood concentration levels are neither feasible or possible to compare the two products (e.g. inhaled corticosteroids), then pharmacodynamic endpoints rather than pharmacokinetic endpoints (see below) are used for comparison. For a pharmamacokinetic comparison, the plasma concentration data are used to assess key pharmacokinetic parameters such as area under the curve (AUC), peak concentration (C<sub>max</sub>), time to peak concentration (T<sub>max</sub>), and absorption lag time (t<sub>lag</sub>). Testing should be conducted at several different doses, especially when the drug displays non-linear pharmacokinetics.</p>
<p>In addition to data from bioequivalence studies, other data may need to be submitted to meet regulatory requirements for bioequivalence. Such evidence may include:</p>
<ul>
<li>analytical method validation</li>
<li><i>in vitro-in vivo</i> correlation studies</li>
</ul>
<p><a name="Regulatory_definition" id="Regulatory_definition"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: Regulatory definition">edit</a>]</span> <span class="mw-headline">Regulatory definition</span></h2>
<p><a name="Australia" id="Australia"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: Australia">edit</a>]</span> <span class="mw-headline">Australia</span></h3>
<p>In <a href="../../../a/u/s/Australia.html" title="Australia">Australia</a>, the <a href="../../../t/h/e/Therapeutics_Goods_Administration_167e.html" title="Therapeutics Goods Administration">Therapeutics Goods Administration</a> (TGA) considers preparations to be bioequivalent if the 90% <a href="../../../c/o/n/Confidence_interval.html" title="Confidence interval">confidence intervals</a> (90% CI) of the transformed <a href="../../../n/a/t/Natural_log.html" title="Natural log">natural</a> log ratios, between the two preparations, of C<sub>max</sub> and AUC lie in the range 0.80-1.25. T<sub>max</sub> should also be similar between the products. (Birkett2003)</p>
<p>There are tighter requirements for drugs with a narrow <a href="../../../t/h/e/Therapeutic_index.html" title="Therapeutic index">therapeutic index</a> and/or saturable metabolism – thus no generic products exist on the Australian market for <a href="../../../d/i/g/Digoxin.html" title="Digoxin">digoxin</a> or <a href="../../../p/h/e/Phenytoin.html" title="Phenytoin">phenytoin</a> for instance.</p>
<p><a name="Europe" id="Europe"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: Europe">edit</a>]</span> <span class="mw-headline">Europe</span></h3>
<p>According to European regulations <a href="http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf" class="external text" title="http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf" rel="nofollow">EMEA-CPMP, Note for Guidance on the investigation of Bioavailability and Bioequivalence, London, July 2001 CPMP/EWP/QWP/1401/98</a> two medicinal products are bioequivalent if they are pharmaceutically equivalent or pharmaceutical alternatives and if their bioavailabilities after administration in the same molar dose are similar to such a degree that their effects, with respect to both efficacy and safety, will be essentially the same.</p>
<p><a name="United_States" id="United_States"></a></p>
<h3><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: United States">edit</a>]</span> <span class="mw-headline">United States</span></h3>
<p>The FDA considers two products bioequivalent if the 90% CI of the relative mean C<sub>max</sub>, AUC<sub>(0-t)</sub> and AUC<sub>(0-∞)</sub> of the test (e.g. generic formulation) to reference (e.g. innovator brand formulation) should be within 80.00% to 125.00% in the fasting state. Although there are a few exceptions, generally a bioequivalent comparison of Test to Reference formulations also requires administration after an appropriate meal at a specified time before taking the drug, a so-called "fed" or "food-effect" study. A food-effect study requires the same statistical evaluation as the fasting study, described above.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../g/e/n/Generic_drug.html" title="Generic drug">generic drug</a></li>
<li><a href="../../../p/h/a/Pharmacokinetics.html" title="Pharmacokinetics">pharmacokinetics</a></li>
<li><a href="../../../c/l/i/Clinical_trial.html" title="Clinical trial">clinical trial</a></li>
</ul>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h2>
<ul>
<li>Hussain AS, et al. <a href="http://www.dissolutiontech.com/DTresour/599articles/Biopharm_Class2_copy.html" class="external text" title="http://www.dissolutiontech.com/DTresour/599articles/Biopharm_Class2_copy.html" rel="nofollow">The Biopharmaceutics Classification System: Highlights of the FDA's Draft Guidance</a> Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration.</li>
<li>Mills D (2005). <a href="http://www.ibpassociation.org/clintrials.html" class="external text" title="http://www.ibpassociation.org/clintrials.html" rel="nofollow">Regulatory Agencies Do Not Require Clinical Trials To Be Expensive</a> International Biopharmaceutical Association: IBPA Publications.</li>
<li><a href="http://www.fda.gov/cder/ogd/" class="external text" title="http://www.fda.gov/cder/ogd/" rel="nofollow">FDA CDER Office of Generic Drugs</a> – further U.S. information on bioequivalence testing and generic drugs</li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Bioequivalence.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>Birkett D (2003). <a href="http://www.australianprescriber.com/index.php?content=/magazines/vol26no4/85_87_generics.htm" class="external text" title="http://www.australianprescriber.com/index.php?content=/magazines/vol26no4/85_87_generics.htm" rel="nofollow">Generics – equal or not?</a> <i>Aust Presc</i> <b>26</b> (4): 85-7.</li>
<li>Food and Drug Administration (2003). <a href="http://www.fda.gov/cder/guidance/5356fnl.pdf" class="external text" title="http://www.fda.gov/cder/guidance/5356fnl.pdf" rel="nofollow">Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations</a>. Rockville (MD): FDA.</li>
<li>EMEA, CPMP, Note for Guidance on the investigation of Bioavailability and Bioequivalence, London, July 2001 <a href="http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf" class="external text" title="http://www.emea.eu.int/pdfs/human/ewp/140198en.pdf" rel="nofollow">CPMP/EWP/QWP/1401/98</a>.</li>
</ul>

<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/o/Bioequivalence.html">http://en.wikipedia.org../../../b/i/o/Bioequivalence.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../p/h/a/Category%7EPharmacokinetics_e6c9.html" title="Category:Pharmacokinetics">Pharmacokinetics</a></span> | <span dir='ltr'><a href="../../../c/l/i/Category%7EClinical_research_260b.html" title="Category:Clinical research">Clinical research</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/o/Bioequivalence.html">Article</a></li><li id="ca-talk"
	       class="new"	       ><a href="../../../b/i/o/Talk%7EBioequivalence_ba86.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Bioequivalence">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/i/o/Bio%C3%A4quivalenz.html">Deutsch</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 22:31, 28 September 2006 by Wikipedia user <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>. Based on work by Wikipedia user(s) <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, Rescigno, <a href="../../../k/k/u/User%7EKku_5886.html" title="User:Kku">Kku</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../s/y/r/User%7ESyrthiss_6bb0.html" title="User:Syrthiss">Syrthiss</a> and Bberry and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
